Dr. Gilles Huberfeld, MD, PhD, is leading the 1st humans patient investigations of Panaxium’s next-generation iontronic brain computer interface in 2023 in Paris, France.
A bilayered PVA/PLGA-bioresorbable shuttle to improve the implantation of flexible neural probes
3D conducting polymer platforms for electrical control of protein conformation and cellular functions
Electrical control of protein conformation
Organic electrochemical transistors for clinical applications
Understanding volumentric capacitance in conducting polymers
Organic electrochemical transistors with maximum transconductance at zero gate bias
Dr. Gilles Huberfeld to Lead First In-Human Trial of Panaxium’s Next-Generation Brain Computer Interface
Panaxium Wins 1st Place Jury Prize at 2022 Brain Innovation Days
Panaxium won the 2022 Brain Innovation Days 1st Place Jury Prize at the conference’s pitch competition held in Brussels, Belgium, on October 12, 2022.
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR
Panaxium is excited to share a development partnership with Synaptive Medical